BGB-A317-A3055-101
Active, not recruiting
BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors
BeOne Study ID 
BGB-A317-A3055-101
ClinicalTrials.gov ID
EudraCT Number
2023-505322-34-00
China Drug Trials ID
CTR20241681
Study Overview
Sex:
All
Age: 18 Years / N/A
No Study Documents
Study Overview
Sex:
All
Age: 18 Years / N/A
No Study Documents